Gland Pharma has informed that a meeting of the Board of Directors of Gland Pharma will be held on Monday, February 03, 2025 to consider and approve the Un-Audited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2024. In continuation to earlier intimation dated December 27, 2024; Gland Pharma has informed that the trading window, which was closed from Saturday, December 28, 2024 in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended; will reopen on Thursday, February 06, 2025. The Investor/Analyst call will be held on Monday, February 03, 2025 at 18:30 Hrs (IST). Further details will be intimated to the stock exchanges and published on the Company’s website (www.glandpharma.com) in due course.
The above information is a part of company’s filings submitted to BSE.
